SEC Filing | Veradigm Inc.

View:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

FORM 4

[X] Check this box if no longer OMB APROVAL
subject to Section 16. Form 4 or OMB NUMBER: 3235-0287
Form 5 obligations may continue. Expires: September 30, 1998
See Instruction 1(b). Estimated average burden
hours per response........0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935
or Section 30(f) of the Investment Company Act of 1940

(Print or Type Responses)

1. Name and Address of Reporting Person*

Morgan Stanley Dean Witter & Co.(1)
- -----------------------------------------------------------------------------
(Last) (First) (Middle)

1585 Broadway
- -----------------------------------------------------------------------------
(Street)

New York NY 10036
- -----------------------------------------------------------------------------
(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol

Allscripts Healthcare Solutions, Inc. (MDRX)
- -----------------------------------------------------------------------------

3. I.R.S. or Social Security Number of Reporting Person (Voluntary)

- -----------------------------------------------------------------------------

4. Statement for Month/Year

06/01
- -----------------------------------------------------------------------------

5. If Amendment, Date of Original (Month/Day/Year)

- -----------------------------------------------------------------------------

6. Relationship of Reporting Person(s) to Issuer (Check all applicable)

Director X 10% Owner
--- ---

Officer (give title below) Other (specify below)
--- ---

- ----------------------------------------------------------------------------

7. Individual or Joint/Group Filing (Check Applicable Line)

Form filed by One Reporting Person
- ---

X Form filed by More than One Reporting Person
- ---

Table I -- Non-Derivative Securities Acquired, Disposed of, or
Beneficially Owned

1. Title of Security 2. Trans- 3. Trans- 4. Securities Acquired 5. Amount of Securities 6. Ownership 7. Nature of
(Instr. 3) action action (A) or Disposed of Beneficially Owned Form: Direct Indirect
Date Code (D) (Instr. 3, 4 at End of Month (D) or In- Beneficial
(Instr.8) and 5) (Instr. 3 and 4) direct (I) Ownership
(Month/ (Instr. 4) (Instr. 4)
Day/ (A) or
Year) Code V Amount (D) Price
- ------------------------- --------- ---- --- ------- --- --------- -------------------- -------------- -------------

Common Stock 06/15/01 J2 1,000,000 D 0 3,015,848 I(4) through
participation

Common Stock 06/15/01 J3 61,785 A 0 3,015,848 I(4) through
participation

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

(Over)
SEC 1474 (7-96)

FORM 4 (continued)

Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of 2. Conversion or 3. Transaction Date 4. Transaction 5. Number of 6. Date Exercisable and
Derivative Exercise Price (Month/Day/Year) Code Derivative Expiration Date
Security of Derivative (Instr. 8) Securities (Month/Day/Year)
(Instr. 3) Security Acquired (A)
or Disposed of
(D) (Instr. 3,
4 and 5)
Date Expiration
Code V (A) (D) Exercisable Date
- ------------------------------------------------------------------------------------------------------------------------------------

1. Title of 7. Title and Amount of 8. Price of 9. Number of 10. Ownership 11. Nature of
Derivative Underlying Securities Derivative derivative Form of Indirect
Security (Instr. 3 and 4) Security Securities Derivative Beneficial
(Instr. 3) (Instr. 5) Beneficially Security: Ownership
Amount Owned at End Direct (D) (Instr. 4)
or of Month or Indirect
Number (Instr. 4) (I)
of (Instr. 4)
Title Shares
- ------------------------------------------------------------------------------------------------------------------------------------

Explanation of Responses:

(1) Please see attached Joint Filer Information.

(2) Morgan Stanley Venture Partners III, L.P., Morgan Stanley Venture /s/ Peter Vogelsang
Investors III, L.P. and The Morgan Stanley Venture Partners -------------------------------
Entrepreneur Fund, L.P. (collectively, the "Funds"), of which Morgan **Signature of Reporting Person
Stanley Venture Partners III, L.L.C. is a general partner (the By: Peter Vogelsang,
"General Partner"), made an in-kind distribution of 1,000,000 shares of authorized signatory for
Common Stock (the "Distribution"). The reported securities Morgan Stanley Dean Witter & Co.
were distributed to the partners of the Funds in proportion to
their partnership interests in the Funds.

(3) Morgan Stanley Venture Capital III, Inc. ("MSVC III, Inc.")
received 61,785 shares of Common Stock in the Distribution.

(4) The reported securities are owned directly by the Funds and
MSVC III, Inc. MSVC III, Inc., as an institutional managing
member of the General Partner, and Morgan Stanley Dean Witter & Co.,
as the ultimate parent company of MSVC III, Inc., each disclaim
beneficial ownership of the securities owned by the Funds except to
the extent of their pecuniary interests therein.

**Intentional misstatements or omissions of facts constitute Federal /s/ Debra Abramovitz July 9, 2001
Criminal Violations. --------------------------------------- -----------------
**Signature of Reporting Person Date
Note: File three copies of this Form, one of which must be manually By: Debra Abramovitz, Vice President
signed. and Treasurer of Morgan Stanley
If space is insufficient, see Instruction 6 for procedure. Venture Capital III, Inc.,
institutional managing member of the
Potential persons who are to respond to the collection of information General Partner of the Fund, for
contained in this form are not required to respond unless the form each of these entities.
displays a currently valid OMB Number.

Page 2
SEC 1474 (7-96)

JOINT FILER INFORMATION

Each of the following joint filers has designated Morgan Stanley Dean
Witter & Co. ("MSDW") as the "Designated Filer" for purposes of the attached
Form 4:

(1) Morgan Stanley Venture Capital III, Inc. ("MSVC III, Inc.")
1221 Avenue of the Americas
New York, New York 10020

(2) Morgan Stanley Venture Partners III, L.L.C. ("MSVP III, L.L.C.")
1221 Avenue of the Americas
New York, New York 10020

(3) Morgan Stanley Venture Partners III, L.P. ("MSVP III, L.P.")
1221 Avenue of the Americas
New York, New York 10020

(4) The Morgan Stanley Venture Partners Entrepreneur Fund, L.P. (the
"Entrepreneur Fund")
1221 Avenue of the Americas
New York, New York 10020

(5) Morgan Stanley Venture Investors III, L.P. ("MSVI III, L.P.")
1221 Avenue of the Americas
New York, New York 10020

Issuer & Ticker Symbol: Allscripts Heathcare Solutions, Inc. (MDRX)
Dates of Events Requiring Statement: 06/15/01

Signature: /s/ Peter Vogelsang
---------------------------------------------------------------------
By: Peter Vogelsang,
as authorized signatory for MSDW.

Signature: /s/ Debra Abramovitz
---------------------------------------------------------------------
By: Debra Abramovitz,
as Vice President and Treasurer of MSVC III, Inc.,
the institutional managing member of MSVP III, L.L.C.,
the General Partner of MSVP III, L.P.,
the Entrepreneur Fund and MSVI III, L.P.